Literature DB >> 34297786

SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts.

Rafail Nikolaos Tasakis1,2, Georgios Samaras1,3, Anna Jamison4, Michelle Lee5, Alexandra Paulus4, Gabrielle Whitehouse4, Laurent Verkoczy6, F Nina Papavasiliou1, Marilyn Diaz6.   

Abstract

Since the first case of COVID-19 in December 2019 in Wuhan, China, SARS-CoV-2 has spread worldwide and within a year and a half has caused 3.56 million deaths globally. With dramatically increasing infection numbers, and the arrival of new variants with increased infectivity, tracking the evolution of its genome is crucial for effectively controlling the pandemic and informing vaccine platform development. Our study explores evolution of SARS-CoV-2 in a representative cohort of sequences covering the entire genome in the United States, through all of 2020 and early 2021. Strikingly, we detected many accumulating Single Nucleotide Variations (SNVs) encoding amino acid changes in the SARS-CoV-2 genome, with a pattern indicative of RNA editing enzymes as major mutators of SARS-CoV-2 genomes. We report three major variants through October of 2020. These revealed 14 key mutations that were found in various combinations among 14 distinct predominant signatures. These signatures likely represent evolutionary lineages of SARS-CoV-2 in the U.S. and reveal clues to its evolution such as a mutational burst in the summer of 2020 likely leading to a homegrown new variant, and a trend towards higher mutational load among viral isolates, but with occasional mutation loss. The last quartile of 2020 revealed a concerning accumulation of mostly novel low frequency replacement mutations in the Spike protein, and a hypermutable glutamine residue near the putative furin cleavage site. Finally, end of the year data and 2021 revealed the gradual increase to prevalence of known variants of concern, particularly B.1.1.7, that have acquired additional Spike mutations. Overall, our results suggest that predominant viral genomes are dynamically evolving over time, with periods of mutational bursts and unabated mutation accumulation. This high level of existing variation, even at low frequencies and especially in the Spike-encoding region may become problematic when super-spreader events, akin to serial Founder Events in evolution, drive these rare mutations to prominence.

Entities:  

Year:  2021        PMID: 34297786     DOI: 10.1371/journal.pone.0255169

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  13 in total

Review 1.  Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency.

Authors:  Nathan M Markarian; Gaël Galli; Dhanesh Patel; Mark Hemmings; Priya Nagpal; Albert M Berghuis; Levon Abrahamyan; Silvia M Vidal
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

2.  An Electrostatically-steered Conformational Selection Mechanism Promotes SARS-CoV-2 Spike Protein Variation.

Authors:  Marija Sorokina; Jaydeep Belapure; Christian Tüting; Reinhard Paschke; Ioannis Papasotiriou; João P G L M Rodrigues; Panagiotis L Kastritis
Journal:  J Mol Biol       Date:  2022-05-17       Impact factor: 6.151

Review 3.  Microbial ecology and evolution is key to pandemics: using the coronavirus model to mitigate future public health challenges.

Authors:  Emmanuel Sunday Okeke; Chinasa Valerie Olovo; Ndidi Ethel Nkwoemeka; Charles Obinwanne Okoye; Chidiebele Emmanuel Ikechukwu Nwankwo; Chisom Joshua Onu
Journal:  Heliyon       Date:  2022-05-18

4.  The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.

Authors:  Kyumin Kim; Peter Calabrese; Shanshan Wang; Chao Qin; Youliang Rao; Pinghui Feng; Xiaojiang S Chen
Journal:  bioRxiv       Date:  2022-04-07

5.  Mapping Data to Deep Understanding: Making the Most of the Deluge of SARS-CoV-2 Genome Sequences.

Authors:  Bahrad A Sokhansanj; Gail L Rosen
Journal:  mSystems       Date:  2022-03-21       Impact factor: 7.324

Review 6.  Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?

Authors:  Abdul Hawil Abas; Siti Marfuah; Rinaldi Idroes; Diah Kusumawaty; Moon Nyeo Park; Abolghasem Siyadatpanah; Fahad A Alhumaydhi; Shafi Mahmud; Trina Ekawati Tallei; Talha Bin Emran; Bonglee Kim
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

7.  The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2.

Authors:  Trudy M Wassenaar; Visanu Wanchai; Gregory Buzard; David W Ussery
Journal:  FEMS Microbiol Rev       Date:  2022-05-06       Impact factor: 15.177

8.  The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.

Authors:  Kyumin Kim; Peter Calabrese; Shanshan Wang; Chao Qin; Youliang Rao; Pinghui Feng; Xiaojiang S Chen
Journal:  Res Sq       Date:  2022-04-12

9.  Commentary on "Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2".

Authors:  F Martignano; S Di Giorgio; G Mattiuz; S G Conticello
Journal:  J Appl Genet       Date:  2022-03-12       Impact factor: 2.653

10.  Detection of A-to-I RNA Editing in SARS-COV-2.

Authors:  Ernesto Picardi; Luigi Mansi; Graziano Pesole
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.